Cargando…
Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry
BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typica...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922009/ https://www.ncbi.nlm.nih.gov/pubmed/24502792 http://dx.doi.org/10.1186/1750-1172-9-19 |
_version_ | 1782303394388508672 |
---|---|
author | Bonesso, Laurent Piraud, Monique Caruba, Céline Van Obberghen, Emmanuel Mengual, Raymond Hinault, Charlotte |
author_facet | Bonesso, Laurent Piraud, Monique Caruba, Céline Van Obberghen, Emmanuel Mengual, Raymond Hinault, Charlotte |
author_sort | Bonesso, Laurent |
collection | PubMed |
description | BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typically results in the abnormal accumulation of uncompletely degraded oligosaccharides in the urine. Since the clinical features of many of these disorders are not specific for a single enzyme deficiency, unambiguous screening is critical to limit the number of costly enzyme assays which otherwise must be performed. METHODS: Here we provide evidence for the advantages of using a MALDI-TOF/TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometric (MS) method for screening oligosaccharidoses. Urine samples from previously diagnosed patients or from unaffected subjects were randomly divided into a training set and a blind testing set. Samples were directly analyzed without prior treatment. RESULTS: The characteristic MS and MS/MS molecular profiles obtained allowed us to identify fucosidosis, aspartylglucosaminuria, GM1 gangliosidosis, Sandhoff disease, α-mannosidosis, sialidosis and mucolipidoses type II and III. CONCLUSIONS: This method, which is easily run in less than 30 minutes, is performed in a single step, and is sensitive and specific. Invaluable for clinical chemistry purposes this MALDI-TOF/TOF mass spectrometry procedure is semi-automatizable and suitable for the urinary screening of oligosacharidoses. |
format | Online Article Text |
id | pubmed-3922009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39220092014-02-13 Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry Bonesso, Laurent Piraud, Monique Caruba, Céline Van Obberghen, Emmanuel Mengual, Raymond Hinault, Charlotte Orphanet J Rare Dis Research BACKGROUND: Oligosaccharidoses, which belong to the lysosomal storage diseases, are inherited metabolic disorders due to the absence or the loss of function of one of the enzymes involved in the catabolic pathway of glycoproteins and indirectly of glycosphingolipids. This enzymatic deficiency typically results in the abnormal accumulation of uncompletely degraded oligosaccharides in the urine. Since the clinical features of many of these disorders are not specific for a single enzyme deficiency, unambiguous screening is critical to limit the number of costly enzyme assays which otherwise must be performed. METHODS: Here we provide evidence for the advantages of using a MALDI-TOF/TOF (matrix-assisted laser desorption ionization time-of-flight) mass spectrometric (MS) method for screening oligosaccharidoses. Urine samples from previously diagnosed patients or from unaffected subjects were randomly divided into a training set and a blind testing set. Samples were directly analyzed without prior treatment. RESULTS: The characteristic MS and MS/MS molecular profiles obtained allowed us to identify fucosidosis, aspartylglucosaminuria, GM1 gangliosidosis, Sandhoff disease, α-mannosidosis, sialidosis and mucolipidoses type II and III. CONCLUSIONS: This method, which is easily run in less than 30 minutes, is performed in a single step, and is sensitive and specific. Invaluable for clinical chemistry purposes this MALDI-TOF/TOF mass spectrometry procedure is semi-automatizable and suitable for the urinary screening of oligosacharidoses. BioMed Central 2014-02-06 /pmc/articles/PMC3922009/ /pubmed/24502792 http://dx.doi.org/10.1186/1750-1172-9-19 Text en Copyright © 2014 Bonesso et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Bonesso, Laurent Piraud, Monique Caruba, Céline Van Obberghen, Emmanuel Mengual, Raymond Hinault, Charlotte Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title | Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title_full | Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title_fullStr | Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title_full_unstemmed | Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title_short | Fast urinary screening of oligosaccharidoses by MALDI-TOF/TOF mass spectrometry |
title_sort | fast urinary screening of oligosaccharidoses by maldi-tof/tof mass spectrometry |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922009/ https://www.ncbi.nlm.nih.gov/pubmed/24502792 http://dx.doi.org/10.1186/1750-1172-9-19 |
work_keys_str_mv | AT bonessolaurent fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry AT piraudmonique fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry AT carubaceline fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry AT vanobberghenemmanuel fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry AT mengualraymond fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry AT hinaultcharlotte fasturinaryscreeningofoligosaccharidosesbymalditoftofmassspectrometry |